The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

The virus often mutates by simply deleting small pieces of its genetic code. The mutations "disguise" the virus from antibodies.

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University ...

I know there is both a growing interest in – and quite a bit of confusion about – the state of COVID-19 antibody testing. I wanted to take a moment to clear up some of the confusion.

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine ...

Few healthcare workers in the United Kingdom who recovered from COVID-19 and had immunoglobulin G (IgG) antibodies against the virus were reinfected over the next 6 months, according to a study ...

Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...

A new report suggests that more Americans may be walking around with bird flu − and not even know it. Researchers from the ...

Shares in Sorrento Therapeutics rose 158% on Friday after it revealed plans to start human trials of an antibody therapy that achieved complete inhibition of the coronavirus in preclinical studies.

AbbVie is to begin clinical development of an antibody designed to neutralise the SARS-CoV-2 coronavirus after licensing the therapy in from Harbour BioMed and Utrecht University.